Allgens(688613)2024-04-29 07:42Company Overview - Aojing Medical Technology Co., Ltd. was established in 2004, focusing on high-end regenerative medical materials and implantable medical devices [2] - The company developed a biomimetic bone material that closely resembles natural human bone tissue in composition and structure, achieving industrialization and clinical transformation by 2011 [2] - Aojing Medical has received 3 Class III medical device registrations from China's NMPA and 1 FDA 510(k) market entry approval [2] Awards and Recognitions - The company was awarded the "National Key New Product" and "Beijing Independent Innovation Product" titles [2] - In 2023, Aojing Medical won a gold medal at the 48th Geneva International Exhibition of Inventions [3] - The company has received multiple national awards, including the National Natural Science Award (2nd class) in 2011 and the National Technological Invention Award (2nd class) in 2008 [3] Product Applications - Aojing Medical's products are used for filling and guiding the repair of bone defects caused by trauma, degenerative diseases, and surgeries, primarily in orthopedics, oral surgery, and neurosurgery [3] - The company completed a 100% acquisition of HumanTech Dental in 2024, entering the dental implant market with high-quality products [3] Market Insights - The reimbursement rate for artificial bone under medical insurance generally ranges from 80% to 85% [4] - The dental implant industry is expected to grow significantly, with annual clinical implant numbers projected to exceed 10 million by 2026 and 20 million by 2028 [4] - The implementation of centralized procurement for dental implants is anticipated to lower prices and increase the patient base, benefiting the clinical use of artificial bone repair materials [5] Strategic Acquisitions - The acquisition of HumanTech Dental is aimed at enhancing product offerings and optimizing product structure, while also facilitating the development of existing oral bone repair materials [4] - HumanTech Dental has over 70 years of experience in high-end precision manufacturing and has obtained market access qualifications in multiple countries [5] Research and Development - Aojing Medical is leading a national key research project focused on developing new functional biomimetic collagen materials for pediatric bone defect regeneration [5] - The project aims to create customized implants that match children's physiological characteristics, facilitating bone tissue regeneration and aesthetic restoration [6]